Inhibition of AMP-activated protein kinase in respiratory syncytial virus infection activates lipid metabolism


Respiratory syncytial virus (RSV) is most commonly associated with upper respiratory tract infections during childhood. The lipid composition of cells and lipogenic enzymes play an important role in RSV infection. There are controversial data about whether lipid biosynthesis regulators such as AMP-activated protein kinase (AMPK) are deregulated by RSV. Hence, we examined whether the activation state of AMPK is altered in RSV-infected HEp-2 cells. Our data show that RSV infection inhibits AMPK activity, favoring the activation of downstream lipogenic effectors and cellular lipid anabolism in HEp-2 cells.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3


  1. 1.

    Ruckwardt TJ, Morabito KM, Graham BS (2019) Immunological lessons from respiratory syncytial virus vaccine development. Immunity 51:429–442.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Rossey I, Saelens X (2019) Vaccines against human respiratory syncytial virus in clinical trials, where are we now? Expert Rev Vaccines 18:1053–1067.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Ketter E, Randall G (2019) Virus impact on lipids and membranes. Annu Rev Virol 6:319–340.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Jordan TX, Randall G (2017) Dengue virus activates the AMP Kinase-mTOR axis to stimulate a proviral lipophagy. J Virol 91:1–13.

    CAS  Article  Google Scholar 

  5. 5.

    Yeo DSY, Chan R, Brown G et al (2009) Evidence that selective changes in the lipid composition of raft-membranes occur during respiratory syncytial virus infection. Virology 386:168–182.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Chang TH, Segovia J, Sabbah A et al (2012) Cholesterol-rich lipid rafts are required for release of infectious human respiratory syncytial virus particles. Virology 422:205–213.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Lay MK, González PA, León MA et al (2013) Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response. Microbes Infect 15:230–242.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Ohol YM, Wang Z, Kemble G, Duke G (2015) Direct inhibition of cellular fatty acid synthase impairs replication of respiratory syncytial virus and other respiratory viruses. PLoS ONE 10:1–20.

    CAS  Article  Google Scholar 

  9. 9.

    Carling D, Clarke PR, Zammit VA, Hardie DG (1989) Purification and characterization of the AMP-activated protein kinase: Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur J Biochem 186:129–136.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Hardie DG, Pan DA (2002) Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 30:1064–1070.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Li Y, Xu S, Mihaylova MM et al (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 13:376–388.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Horton JD, Goldstein JL, Brown MS (2002) SREBPs. Most 109:1125–1131.

    CAS  Article  Google Scholar 

  13. 13.

    Soto-Acosta R, Bautista-Carbajal P, Cervantes-Salazar M et al (2017) DENV up-regulates the HMG-CoA reductase activity through the impairment of AMPK phosphorylation: a potential antiviral target. PLoS Pathog.

    Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Wang ZQ, Yu Y, Zhang XH et al (2010) Human adenovirus 36 decreases fatty acid oxidation and increases de novo lipogenesis in primary cultured human skeletal muscle cells by promoting Cidec/FSP27 expression. Int J Obes 34:1355–1364.

    CAS  Article  Google Scholar 

  15. 15.

    Tsai WL, Chang TH, Sun WC et al (2017) Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase. Oncotarget 8:91928–91937.

  16. 16.

    Activation D (2018) crossm Protein Kinase (AMPK) by PF-06409577 Inhibits Flavivirus Infection through Modification of Host Cell Lipid Metabolism. 1–11

  17. 17.

    Xie W, Wang L, Dai Q et al (2015) Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation. J Mol Cell Cardiol 85:155–167.

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    McKimm-Breschkin JL (2004) A simplified plaque assay for respiratory syncytial virus - Direct visualization of plaques without immunostaining. J Virol Methods 120:113–117.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Sarmiento RE, Tirado R, Gómez B (2002) Characteristics of a respiratory syncytial virus persistently infected macrophage-like culture. Virus Res 84:45–58.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Stewart JCM (1980) Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104:10–14.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Zhao Z, Xu Y (2010) An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples. J Lipid Res 51:652–659.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Jeon SM (2016) Regulation and function of AMPK in physiology and diseases. Exp Mol Med 48:e245.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Chen X, Luo Y, Wang M, et al (2019) Wuhu decoction regulates dendritic cell autophagy in the treatment of respiratory syncytial virus (RSV)-induced mouse asthma by AMPK/ULK1 signaling pathway. Med Sci Monit 25:5389–5400.

  24. 24.

    Li M, Li J, Zeng R et al (2018) Respiratory syncytial virus replication is promoted by autophagy-mediated inhibition of apoptosis. J Virol 92:1–21.

    CAS  Article  Google Scholar 

  25. 25.

    Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 80(307):1098–1101.

  26. 26.

    Dan HC, Antonia RJ, Baldwin AS (2016) PI3K/Akt promotes feedforward mTORC2 activation through IKKα. Oncotarget 7:21064–21075.

  27. 27.

    Gower TL, Graham BS (2001) Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro. Antimicrob Agents Chemother 45:1231–1237.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Martín-Vicente M, González-Riaño C, Barbas C et al (2020) Metabolic changes during respiratory syncytial virus infection of epithelial cells. PLoS ONE 15:1–17.

    CAS  Article  Google Scholar 

  29. 29.

    Shan J, Qian W, Shen C et al (2018) High-resolution lipidomics reveals dysregulation of lipid metabolism in respiratory syncytial virus pneumonia mice. RSC Adv 8:29368–29377.

    CAS  Article  Google Scholar 

  30. 30.

    garcia1993-NetP font IBs.pdf

  31. 31.

    Rincheval V, Lelek M, Gault E et al (2017) Functional organization of cytoplasmic inclusion bodies in cells infected by respiratory syncytial virus. Nat Commun 8:1–11.

    CAS  Article  Google Scholar 

  32. 32.

    Li Z, Guo D, Qin Y, Chen M (2019) PI4KB on inclusion bodies formed by ER membrane remodeling facilitates replication of human parainfluenza virus type 3. Cell Rep 29:2229-2242.e4.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Dcd R (2007) Chapter 12 Chapter 12. 1732:46–48.

Download references


This study was supported by the National Council on Science and Technology CONACYT (CB-2015-01-255007 to M.L.J.) and Instituto Nacional de Perinatología “Isidro Espinosa de los Reyes” (212250-3210-21007-03-15 to M.L.J.) L.D.G.G, T.A.V.P. received a fellowship from CONACYT. Additionally, M.LJ., M.M.C., J.G.C., H.A.R., and A.C.H.R. acknowledge their membership of the National System of Researches (SNI).

Author information




Conceived and designed the experiments: LDGG, MMC, MLJ. Performed the experiments: LDGG, MMC, TAVP, JMUA. Contributed reagents/materials/analysis tools: HAR, ACHR, GLR. Wrote the paper: MLJ and MMC. Coordinated and facilitated the project: MLJ. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Moisés León-Juárez.

Ethics declarations

Conflict of interest

All authors declare that no conflicts of interest exist.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Handling Editor: Bert K. Rima.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

González-García, L.D., Martínez-Castillo, M., Vargas-Pavía, T.A. et al. Inhibition of AMP-activated protein kinase in respiratory syncytial virus infection activates lipid metabolism. Arch Virol 166, 1177–1182 (2021).

Download citation